FI933284A7 - Benzimidazol, dessa foereningar innehaollande laekemedel och foerfarande foer dess framstaellning - Google Patents
Benzimidazol, dessa foereningar innehaollande laekemedel och foerfarande foer dess framstaellning Download PDFInfo
- Publication number
- FI933284A7 FI933284A7 FI933284A FI933284A FI933284A7 FI 933284 A7 FI933284 A7 FI 933284A7 FI 933284 A FI933284 A FI 933284A FI 933284 A FI933284 A FI 933284A FI 933284 A7 FI933284 A7 FI 933284A7
- Authority
- FI
- Finland
- Prior art keywords
- benzimidazol
- foerfarande foer
- och foerfarande
- foer dess
- dess framstaellning
- Prior art date
Links
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4224133A DE4224133A1 (de) | 1992-07-22 | 1992-07-22 | Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI933284A0 FI933284A0 (fi) | 1993-07-21 |
| FI933284A7 true FI933284A7 (fi) | 1994-01-23 |
Family
ID=6463804
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI933284A FI933284A7 (fi) | 1992-07-22 | 1993-07-21 | Benzimidazol, dessa foereningar innehaollande laekemedel och foerfarande foer dess framstaellning |
Country Status (20)
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4233590A1 (de) * | 1992-10-06 | 1994-04-07 | Thomae Gmbh Dr K | Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| DE4304455A1 (de) * | 1993-02-15 | 1994-08-18 | Bayer Ag | Heterocyclisch substituierte Phenyl-cyclohexan-carbonsäurederivate |
| DE4324580A1 (de) * | 1993-07-22 | 1995-01-26 | Thomae Gmbh Dr K | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| DE19503160A1 (de) * | 1995-02-01 | 1996-08-08 | Bayer Ag | Verwendung von Phenylcyclohexylcarbonsäureamiden |
| BR9612434A (pt) * | 1995-12-28 | 1999-12-28 | Fujiwasa Pharmaceutical Co Ltd | Derivados de benzimidazol |
| TW453999B (en) * | 1997-06-27 | 2001-09-11 | Fujisawa Pharmaceutical Co | Benzimidazole derivatives |
| RU2185171C2 (ru) * | 1999-06-25 | 2002-07-20 | Институт нефтехимии и катализа АН РБ и УНЦ РАН | Способ профилактики реокклюзий при операциях на магистральных сосудах |
| HU222773B1 (hu) * | 2000-04-21 | 2003-10-28 | Richter Gedeon Vegyészeti Gyár Rt. | Eljárás egy ismert tetrazolszármazék előállítására |
| WO2005011736A1 (ja) * | 2003-07-30 | 2005-02-10 | Tohoku Techno Arch Co., Ltd. | アルツハイマー病の予防および／または治療剤 |
| DE102004060699A1 (de) * | 2004-12-16 | 2006-06-22 | Ratiopharm Gmbh | Verfahren zur Herstellung von Candesartan |
| RU2427574C2 (ru) * | 2009-07-16 | 2011-08-27 | Государственное образовательное учреждение высшего профессионального образования "Астраханский государственный университет" (АГУ) | Моногидрохлориды и натриевые соли таутомерных 5(6)-алкоксикарбониламинопроизводных 2-арил-1-гидроксибензимидазол-3-оксида с высокой противогрибковой активностью и способ их получения |
| CN101891735B (zh) * | 2009-11-25 | 2012-07-18 | 北京理工大学 | 联苯磺胺异噁唑类化合物、合成方法及用途 |
| CN101921265B (zh) * | 2009-11-25 | 2012-07-04 | 北京理工大学 | 联苯酰胺四唑类化合物、合成方法及用途 |
| CN104105697B (zh) * | 2011-11-03 | 2016-11-09 | 霍夫曼-拉罗奇有限公司 | 二环哌嗪化合物 |
| CN105820125B (zh) * | 2015-01-09 | 2018-12-07 | 北京中医药大学 | 一种用于治疗高血压的化合物及其制备方法和用途 |
| CN105384729B (zh) * | 2015-07-09 | 2019-02-19 | 天津青松华药医药有限公司 | 替米沙坦酯类衍生物及其制备方法与应用 |
| CN106749220B (zh) * | 2017-01-18 | 2019-08-06 | 东华大学 | 一种6’-取代苯并咪唑-4-取代甲基吲哚衍生物及其制备和应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3928177A1 (de) * | 1989-04-08 | 1991-02-28 | Thomae Gmbh Dr K | Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| EP0515535A4 (en) * | 1990-02-13 | 1996-01-17 | Merck & Co Inc | Angiotensin ii antagonists incorporating a substituted benzyl element |
| RU1836357C (ru) * | 1990-07-23 | 1993-08-23 | Др.Карл Томэ ГмбХ | Производные бензимидазола, их изомеры, смеси изомеров, гидраты или их физиологически переносимые соли, обладающие антагонистическими в отношении ангиотензина свойствами |
| SI9210098B (sl) * | 1991-02-06 | 2000-06-30 | Dr. Karl Thomae | Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo |
| DE4237656A1 (de) * | 1992-06-13 | 1993-12-16 | Merck Patent Gmbh | Benzimidazolderivate |
-
1992
- 1992-07-22 DE DE4224133A patent/DE4224133A1/de not_active Withdrawn
-
1993
- 1993-06-12 TW TW082104675A patent/TW229207B/zh active
- 1993-07-12 SK SK732-93A patent/SK73293A3/sk unknown
- 1993-07-20 EP EP93111581A patent/EP0581166A1/de not_active Ceased
- 1993-07-20 CN CN93108085A patent/CN1050122C/zh not_active Expired - Fee Related
- 1993-07-20 IL IL10640893A patent/IL106408A/en not_active IP Right Cessation
- 1993-07-20 CA CA002100927A patent/CA2100927A1/en not_active Abandoned
- 1993-07-20 CZ CZ931449A patent/CZ144993A3/cs unknown
- 1993-07-20 SG SG1996003403A patent/SG43083A1/en unknown
- 1993-07-21 FI FI933284A patent/FI933284A7/fi unknown
- 1993-07-21 KR KR1019930013764A patent/KR940005584A/ko not_active Ceased
- 1993-07-21 AU AU42094/93A patent/AU675433B2/en not_active Expired
- 1993-07-21 PL PL93299754A patent/PL172929B1/pl unknown
- 1993-07-21 HU HU9302115A patent/HUT64955A/hu unknown
- 1993-07-21 NZ NZ248217A patent/NZ248217A/en unknown
- 1993-07-21 NO NO932636A patent/NO300772B1/no not_active IP Right Cessation
- 1993-07-21 JP JP5179485A patent/JPH06179659A/ja active Pending
- 1993-07-21 ZA ZA93529A patent/ZA93529B/xx unknown
- 1993-07-22 MX MX9304424A patent/MX9304424A/es unknown
- 1993-07-22 RU RU93049407A patent/RU2126401C1/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| TW229207B (enrdf_load_stackoverflow) | 1994-09-01 |
| FI933284A0 (fi) | 1993-07-21 |
| RU2126401C1 (ru) | 1999-02-20 |
| CN1083812A (zh) | 1994-03-16 |
| IL106408A0 (en) | 1993-11-15 |
| NO932636D0 (no) | 1993-07-21 |
| DE4224133A1 (de) | 1994-01-27 |
| PL172929B1 (pl) | 1997-12-31 |
| IL106408A (en) | 1998-08-16 |
| CZ144993A3 (en) | 1994-03-16 |
| NO300772B1 (no) | 1997-07-21 |
| CN1050122C (zh) | 2000-03-08 |
| HU9302115D0 (en) | 1993-10-28 |
| EP0581166A1 (de) | 1994-02-02 |
| KR940005584A (ko) | 1994-03-21 |
| ZA93529B (en) | 1995-01-23 |
| NZ248217A (en) | 1996-06-25 |
| SG43083A1 (en) | 1997-10-17 |
| MX9304424A (es) | 1994-01-31 |
| AU4209493A (en) | 1994-01-27 |
| PL299754A1 (en) | 1994-03-21 |
| HUT64955A (en) | 1994-03-28 |
| JPH06179659A (ja) | 1994-06-28 |
| SK73293A3 (en) | 1994-04-06 |
| NO932636L (no) | 1994-01-24 |
| CA2100927A1 (en) | 1994-01-23 |
| AU675433B2 (en) | 1997-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI935440A0 (fi) | Silikonsystem foer modifiering av haeftande och dess anvaendning foer framstaellande av haerdbara, icke-haeftande sammansaettningar | |
| FI933857A7 (fi) | Kondenserade heterocykliska foereningar, deras framstaellning och anvaendning | |
| FI931608L (fi) | Foerfarande och anordning foer terapeutisk, elektromagnetisk behandling | |
| FI934274L (fi) | N-sulfonyl-2-oxi-indolderivat, deras framstaellning och dessa innehaollande farmaceutiska kompositioner | |
| FI931901L (fi) | Azolfoereningar, deras framstaellning och anvaendning | |
| FI931305A7 (fi) | Imidazolfoereningar, deras framstaellning och bruk | |
| FI933942L (fi) | Cykliska ureaderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning | |
| FI930620A0 (fi) | Bensimidazolylderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning | |
| FI932758L (fi) | Ny fosfolipas a1, foerfarande foer framstaellning av denna och dess anvaendning | |
| FI933888L (fi) | Aertproteinhydrolysat, foerfarande foer dess framstaellning och anvaendningdaerav | |
| FI922191A0 (fi) | Sfaerisk lng-tank och dess framstaellningsfoerfarande. | |
| FI931190A7 (fi) | Triazolopyridazinfoereningar, deras framstaellning och anvaendning | |
| FI930711L (fi) | Naftalenderivat, foerfarande foer deras framstaellning och deras syntetiska mellanprodukter | |
| FI924408A0 (fi) | Modifierade viskosfibrer och foerfarande foer dess framstaellning. | |
| FI932649L (fi) | Bifenylderivat, dessa foereningar innehaollande laekemedel och foerfarandefoer deras framstaellning | |
| FI930977L (fi) | Taxanderivat, deras framstaellning och onkologiska anvaendning | |
| FI930318L (fi) | Kaffeprodukt innehaollande rikligt med loeslig naeringsfiber, och foerfarande foer dess framstaellning | |
| FI933284A7 (fi) | Benzimidazol, dessa foereningar innehaollande laekemedel och foerfarande foer dess framstaellning | |
| FI922004A0 (fi) | Maetningsfoerfarande och maetanordning. | |
| FI931599L (fi) | Bensimidazoler, dessa foereningar innehaollande laekemedel och foerfarandefoer deras framstaellning | |
| FI934221A0 (fi) | Piperidinderivat, framstaellning och terapeutisk anvaendning daerav | |
| FI931682A0 (fi) | Tackykininreceptorantagonister, isokinoloner och deras framstaellning | |
| FI925833L (fi) | Tricykliskt triazolderivat, dess framstaellning och dess anvaendning | |
| FI930236L (fi) | Bensimidazoler, dessa foereningar innehaollande laekemedel och foerfarandefoer deras framstaellning | |
| FI931881L (fi) | Maerkta fibrinogen-resepto-antagonister, deras anvaendning och foerfarande foer deras framstaellning |